Original Query: ALL
Previous Study | Return to List | Next Study

Tivozanib + Enzalutamide in Adv Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01885949
Recruitment Status : Active, not recruiting
First Posted : June 25, 2013
Last Update Posted : December 22, 2017
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Dror Michaelson, MD, Massachusetts General Hospital

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018